These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 16079812)

  • 21. Merck moves into biotech.
    Kling J
    Nat Biotechnol; 2006 Jul; 24(7):730. PubMed ID: 16841041
    [No Abstract]   [Full Text] [Related]  

  • 22. Biomedical science. Can money turn Singapore into a biotech juggernaut?
    Normile D
    Science; 2002 Aug; 297(5586):1470-3. PubMed ID: 12202801
    [No Abstract]   [Full Text] [Related]  

  • 23. Golden handcuffs.
    Smaglik P
    Nature; 2003 Jul; 424(6946):351. PubMed ID: 12867990
    [No Abstract]   [Full Text] [Related]  

  • 24. Ontario--hot biotechnology in a cold climate.
    McIntyre H
    Nat Biotechnol; 2001 Jun; 19(6):523-5. PubMed ID: 11385446
    [No Abstract]   [Full Text] [Related]  

  • 25. The National University of Singapore and what it does.
    Halliwell B
    Biointerphases; 2010 Sep; 5(3):FA15-8. PubMed ID: 21171707
    [No Abstract]   [Full Text] [Related]  

  • 26. Biotech jobs are still around despite the recent bumpy ride.
    Smaglik P; Smith A
    Nature; 2002 Jul; 418(6893):4-5. PubMed ID: 12097871
    [No Abstract]   [Full Text] [Related]  

  • 27. Taiwan: Biotech vision.
    Cyranoski D
    Nature; 2003 Feb; 421(6923):672-3. PubMed ID: 12571608
    [No Abstract]   [Full Text] [Related]  

  • 28. Singapore and the Nanyang Technological University--A young country with a young university on the move.
    Andersson B; Mayer T
    Biointerphases; 2010 Sep; 5(3):FA9-14. PubMed ID: 21171719
    [No Abstract]   [Full Text] [Related]  

  • 29. Special: biotech in Russia.
    Rabinovich M; Burghardt N; Gorzka G; Kudryashev M; Leonov A; Konov A
    Biotechnol J; 2007 Jul; 2(7):775-89. PubMed ID: 17615597
    [No Abstract]   [Full Text] [Related]  

  • 30. Across China's frontier.
    Nature; 2006 Feb; 439(7078):781. PubMed ID: 16482125
    [No Abstract]   [Full Text] [Related]  

  • 31. Focus on biotechnology in Australia.
    Boon A
    Drug Discov Today; 2005 Jan; 10(2):85-8. PubMed ID: 15718155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calling for entrepreneurs London.
    Smaglik P
    Nature; 2002 Sep; 419(6904):4-5. PubMed ID: 12239519
    [No Abstract]   [Full Text] [Related]  

  • 33. Singapore--biotechnology development.
    Patel SH
    Clin Invest Med; 2005 Feb; 28(1):12-4. PubMed ID: 15770877
    [No Abstract]   [Full Text] [Related]  

  • 34. Stock options could no longer be the carrot.
    Lawrence S
    Nat Biotechnol; 2005 Feb; 23(2):157. PubMed ID: 15696132
    [No Abstract]   [Full Text] [Related]  

  • 35. Indian biotech's bumpy road.
    Basu P
    Nature; 2007 Nov; 450(7169):580-1. PubMed ID: 18087777
    [No Abstract]   [Full Text] [Related]  

  • 36. Beyond the Triangle.
    Ledford H
    Nature; 2008 Apr; 452(7189):908-9. PubMed ID: 18476298
    [No Abstract]   [Full Text] [Related]  

  • 37. ScanBalt coordinates intellectual property in Northern Europe.
    Sheridan C
    Nat Biotechnol; 2004 Mar; 22(3):355. PubMed ID: 15017988
    [No Abstract]   [Full Text] [Related]  

  • 38. Singapore R&D and globetrotting.
    Lear MJ; Salmons B; Gunzburg WH; Dangerfield JA
    Biotechnol J; 2009 Feb; 4(2):179-85. PubMed ID: 19156748
    [No Abstract]   [Full Text] [Related]  

  • 39. The biotechnology industry: What's next?
    Guertin PA
    Biotechnol J; 2009 Aug; 4(8):1124-31. PubMed ID: 19685466
    [No Abstract]   [Full Text] [Related]  

  • 40. France hails milestone in start-ups.
    Goodman S
    Nature; 2002 Jul; 418(6893):7. PubMed ID: 12097876
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.